Zenas Biopharma, Inc. · NASDAQ:ZBIO

Patrick G. Enright reported a 4.90% stake in Zenas Biopharma, Inc. (Schedule 13D/A)

Event Oct 9, 2025 · Filed Oct 14, 2025

Patrick G. Enright reported a 4.90% stake in Zenas Biopharma, Inc., 2,631,522 shares, with active intent on Oct 9, 2025. Filed Oct 14, 2025 (Schedule 13D/A).

Stake
4.90%
Shares
2,631,522
Intent
Active
What changed
Stake changed
Filed together
6 holders

The filing in full

HolderStakeShares
Longitude Capital Partners IV, LLC3.40%1,832,669
Longitude Venture Partners IV, L.P.3.40%1,832,669
Longitude Prime Partners, LLC1.40%774,530
Longitude Prime Fund, L.P.1.40%774,530
Patrick G. Enright4.90%2,631,522
Juliet Tammenoms Bakker4.90%2,607,199

Source

View original at SEC

Related